Abound Wealth Management’s Collegium Pharmaceutical COLL Stock Holding History

Abound Wealth Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$66	Hold	3	–	–	﹤0.01%	1407
2026 Q2	$109	Sell	3 -1	-25%	-$34	﹤0.01%	1266
2026 Q1	$133	Hold	4	–	–	﹤0.01%	1350
2025 Q4	$186	Hold	4	–	–	﹤0.01%	1209
2025 Q3	$140	Hold	4	–	–	﹤0.01%	1244
2025 Q2	$119	Hold	4	–	–	﹤0.01%	1209
2025 Q1	$120	Sell	4 -1	-20%	-$31	﹤0.01%	1186
2024 Q4	$144	Hold	5	–	–	﹤0.01%	1176
2024 Q3	$194	Sell	5 -2	-29%	-$71	﹤0.01%	1182
2024 Q2	$226	Sell	7 -3	-30%	-$104	﹤0.01%	1073
2024 Q1	$389	Hold	10	–	–	﹤0.01%	1013
2023 Q4	$308	Buy	+10	New	+$250	﹤0.01%	1149

Other funds holding COLL

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Ballast Asset Management Dallas, Texas $230M AUM 34.36% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Abound Wealth Management's COLL Position: Q3 2026 in Review

Abound Wealth Management held its Collegium Pharmaceutical (COLL) position steady in Q3 2026 at 3 shares worth $66. The position accounts for ﹤0.01% of the portfolio, ranked #1407.

Abound Wealth Management first reported a position in COLL in Q4 2023 and has held it in 12 quarters since. The position peaked at $389 in Q1 2024. 90 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

Abound Wealth Management held 3 shares of Collegium Pharmaceutical worth $66 as of Q3 2026.
Abound Wealth Management left its Collegium Pharmaceutical share count unchanged in Q3 2026.
Collegium Pharmaceutical made up ﹤0.01% of Abound Wealth Management's portfolio in Q3 2026, its #1407 holding.
Abound Wealth Management first reported a position in Collegium Pharmaceutical in Q4 2023 and has held it in 12 quarters since.
Abound Wealth Management's Collegium Pharmaceutical position peaked at $389 in Q1 2024.
90 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on Abound Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.